Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Brigido Perdomo"'
Autor:
Anthony S Basile, Reginald L. Dean, Marc Blaustein, Raymond T. Bartus, Dwaine F. Emerich, Brigido Perdomo, Joyce M. Hotz
Publikováno v:
Neuropsychopharmacology. 28:1973-1982
While oral naltrexone is effective in treating alcohol and opiate dependencies, poor patient adherence and widely fluctuating plasma levels limit its efficacy. To overcome these problems, an extended-release formulation of naltrexone (Vivitrex) was d
Autor:
Leah Novak, Heather C. Salzberg-Brenhouse, Anthony S. Basile, Brigido Perdomo, Raymond T. Bartus, Jeffrey H. Kordower, Sam Baldwin, Theodora Kladis, Karen Fu, Sharon Ranelli, Er-Yun Chen, Denise Lafreniere, Ken Hogeland, Dwaine F. Emerich
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 306:218-228
Cyclooxygenases (COXs) are implicated in neurodegenerative processes associated with acute and chronic neurological diseases. Given the potential utility of COX inhibitors in treating these disorders, we examined the nonselective COX inhibitor flurbi
Autor:
Raymond T. Bartus, Denise Lafreniere, Reginald L. Dean, Shelley R. Winn, Mahin F. Arastu, Heather C. Salzberg, Pamela Snodgrass, Joanne Marsh, Brigido Perdomo, Dwaine F. Emerich
Publikováno v:
Pharmaceutical Research. 19:1052-1060
Purpose. The present studies evaluated the ability of injectable, biodegradable microspheres releasing carboplatin, doxorubicin, or 5-fluorouracil to suppress the growth of solid tumors implanted subcutaneously or intramuscularly.
Autor:
Dwaine F, Emerich, Pamela, Snodgrass, Denise, Lafreniere, Reginald L, Dean, Heather, Salzberg, Joanne, Marsh, Brigido, Perdomo, Mahin, Arastu, Shelley R, Winn, Raymond T, Bartus
Publikováno v:
Pharmaceutical research. 19(7)
The present studies evaluated the ability of injectable, biodegradable microspheres releasing carboplatin, doxorubicin, or 5-fluorouracil to suppress the growth of solid tumors implanted subcutaneously or intramuscularly.Seven to 10 days after implan